When should follow-up visits and blood pressure monitoring be performed after initiating hormonal contraception?

When to Check Birth Control and Have Follow-Up

No routine follow-up visit is required after initiating hormonal contraception for healthy women, but blood pressure should be measured at other routine visits for combined hormonal contraceptive (CHC) users. 1

Initial Counseling and Supply

At contraceptive initiation, provide up to a 1-year supply (e.g., 13 pill packs for oral contraceptives) to maximize continuation and reduce unintended pregnancy 1. Advise women to return at any time if they experience side effects, have concerns, or want to change methods 1.

Method-Specific Follow-Up Requirements

Combined Hormonal Contraceptives (Pills, Patch, Ring)

• Blood pressure monitoring is the only required routine assessment 1
• Can be obtained in non-clinical settings (pharmacy, fire station) 1
• While CHCs cause minor BP elevations (0.7 mmHg systolic, 0.4 mmHg diastolic on average), frank hypertension develops in only 0.6-2.8% of users 2, 3
• No specific timing for BP checks is mandated, but should occur at other routine healthcare visits 1

Progestin-Only Pills (POPs)

• No routine follow-up visit required 1
• No blood pressure monitoring needed 1

IUDs (Copper or Levonorgestrel)

• No routine follow-up visit required 1
• Consider checking for IUD string presence at routine visits 1
• Highest PID risk occurs in first 20 days post-insertion, then rates remain very low for years 4

Implants

• No routine follow-up visit required 1
• Advise when removal/replacement is due 1

Injectables (DMPA)

• No routine follow-up visit required 1
• Advise when reinjection is needed 1
• Consider weight monitoring if patient gains >5% baseline weight at 6 months, as this predicts continued weight gain 4

What to Assess at Other Routine Visits

When women present for unrelated healthcare visits, assess:

1. Satisfaction with current method and any concerns 1
2. Changes in health status or medications that would create U.S. MEC category 3 or 4 contraindications 1
3. Blood pressure for CHC users only 1
4. Weight changes if patient is concerned about contraceptive-related weight gain 1

Common Pitfalls to Avoid

• Do not require unnecessary examinations before contraceptive initiation or continuation. Pelvic exams, Pap smears, breast exams, and STI screening are not needed for safe hormonal contraceptive use unless clinically indicated for other reasons 5, 6
• Do not restrict pill pack supply to force follow-up visits. This reduces continuation rates and increases pregnancy risk 1
• Do not delay contraception to wait for next menses or schedule unnecessary appointments 5

Special Populations Requiring More Frequent Follow-Up

Adolescents, women with multiple medical conditions, or those with specific comorbidities may benefit from more frequent monitoring, though specific intervals are not defined in guidelines 1.

Blood Pressure and Hypertension Context

The evidence shows CHCs cause small BP increases but rarely cause clinically significant hypertension 2, 4. However, CHCs are contraindicated in women with uncontrolled hypertension (≥160/100 mmHg) and should be used cautiously in controlled hypertension 3. This makes BP monitoring the single most important routine assessment for CHC users, though no evidence demonstrates that routine follow-up visits improve outcomes 1.